Journal: Cell Death & Disease

Article Title: A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3

doi: 10.1038/s41419-019-1637-7

Figure Lengend Snippet: a Validation of Gapmer-n384546 knockdown efficiency in B-CPAP and KTC-1 cells was determined by qRT-PCR. b CCK-8 proliferation assay in Scrambled Gapmer or Gapmer-n384546 transfected B-CPAP and KTC-1 cells. c Colony formation assay in Scrambled Gapmer or Gapmer-n384546 transfected B-CPAP and KTC-1 cells. d EdU proliferation assay in Scrambled Gapmer or Gapmer-n384546 transfected B-CPAP and KTC-1 cells. e Flow cytometric analysis of apoptosis in Scrambled Gapmer or Gapmer-n384546 transfected B-CPAP and KTC-1 cells. f Tumor size and tumor weight of nude mice was measured and analyzed. g Tumor volume curves of nude mice injected with sh-control and sh-n384546 B-CPAP cells were analyzed. h n384546 expression in tumors collected from nude mice was determined by qRT-PCR. i Immunohistochemical staining of Bcl-2, caspase9 and Ki-67 was used to assess proliferation and apoptosis (400×). Data represent the mean ± SEM of three separate experiments. All experiments were repeated at least three times. * p < 0.05, ** p < 0.01 in independent Student’s t test

Article Snippet: Cell proliferation and viability were analyzed using CCK8 (Cell Counting Kit-8, Dojindo, Japan) following the protocol provided by the manufacturer.

Techniques: Biomarker Discovery, Knockdown, Quantitative RT-PCR, CCK-8 Assay, Proliferation Assay, Transfection, Colony Assay, Injection, Control, Expressing, Immunohistochemical staining, Staining

Journal: Cell Death & Disease

Article Title: A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3

doi: 10.1038/s41419-019-1637-7

Figure Lengend Snippet: a CCK-8 proliferation assay, b EdU proliferation assay, c Flow cytometric analysis of apoptosis, d Transwell invasion assay, e Transwell migration assay, and f Wound healing assay were performed in B-CPAP and KTC-1 cells transfected with Scrambled Gapmer, anti-miR-145, mimic-miR-145, Gapmer-n384546, Gapmer-n384546 + anti-miR-145, Gapmer-n384546 + mimic-miR-145. g The expression of proteins in B-CPAP cells transfected with Scrambled Gapmer, anti-miR-145, mimic-miR-145, Gapmer-n384546, Gapmer-n384546 + anti-miR-145, Gapmer-n384546 + mimic-miR-145 was determined by western blot. Data represent the mean ± SEM of three separate experiments. All experiments were repeated at least three times. * p < 0.05, ** p < 0.01 in independent Student’s t test ( a – f )

Article Snippet: Cell proliferation and viability were analyzed using CCK8 (Cell Counting Kit-8, Dojindo, Japan) following the protocol provided by the manufacturer.

Techniques: CCK-8 Assay, Proliferation Assay, Transwell Invasion Assay, Transwell Migration Assay, Wound Healing Assay, Transfection, Expressing, Western Blot

Journal: Stem Cells International

Article Title: AT7867 Inhibits the Growth of Colorectal Cancer Stem-Like Cells and Stemness by Regulating the Stem Cell Maintenance Factor Ascl2 and Akt Signaling

doi: 10.1155/2023/4199052

Figure Lengend Snippet: AT7867 inhibits the growth and stemness of CSCs. (a, b) By being cocultured with AT7867 for 1 to 3 days, cell viability was measured by performing CCK-8 assay. (c, d) Representative morphology after AT7867 treatment (sphere formation assay) or pretreatment (sphere recovery assay); Scale bar 200 μ m. (e, f) Oct4, Nanog, CD133, and CD44 protein levels were measured by performing Western blot. ∗ P < 0.05, ∗∗ P < 0.01, and ∗∗∗ P < 0.001 vs. the control.

Article Snippet: After incubating at 37°C for 24, 48, and 72 hours, CCK8 reagent (APExBIO, China) was added and the absorbance at 450 nm was measured after incubation for 1 hour.

Techniques: CCK-8 Assay, Tube Formation Assay, Western Blot, Control